会社情報
工場概要
バイオ製造と原料供給における、透明で信頼できるパートナー。
設備と技術力
Morika Bioは中国・青島に拠点を置く原料メーカーです。精密発酵と海洋由来抽出プロセスに注力し、品質管理、安定供給、技術仕様への厳格な準拠を重視しています。
過度な健康訴求型マーケティングではなく、世界中のR&D・調達チームに対して、検証可能な原料データと安定した供給体制を提供します。
基本方針
妥協のない原料品質と検証可能な技術データを提供すること。
提供価値
安定かつ拡張可能なバイオ製造ラインで、お客様のサプライチェーン不安定性を解決すること。
Our Journey
Innovation Milestones
A decade of pioneering precision fermentation and redefining bio-active ingredient safety standards.
Company Founded
Morika Bio established in Qingdao, China, focusing on precision fermentation and bio-active ingredient research and development.
Company Founded
Morika Bio established in Qingdao, China, focusing on precision fermentation and bio-active ingredient research and development.
R&D Platform Development
Launched proprietary AI-assisted synthetic biology platform, accelerating strain screening and product development from lab to commercial scale.
R&D Platform Development
Launched proprietary AI-assisted synthetic biology platform, accelerating strain screening and product development from lab to commercial scale.
HMO Breakthrough — 2'-FL & LNnT
Successfully developed 2'-FL and LNnT via precision yeast fermentation, achieving endotoxin-free production at scale.
HMO Breakthrough — 2'-FL & LNnT
Successfully developed 2'-FL and LNnT via precision yeast fermentation, achieving endotoxin-free production at scale.
First Advanced Manufacturing Award
Recognized as one of China's 'Morning Star' Advanced Manufacturing Enterprises, highlighting our innovation in bio-manufacturing.
First Advanced Manufacturing Award
Recognized as one of China's 'Morning Star' Advanced Manufacturing Enterprises, highlighting our innovation in bio-manufacturing.
National Dairy Innovation Center
Selected as a founding member of the National Dairy Technology Innovation Center Council, reinforcing our role in China's HMO industry.
National Dairy Innovation Center
Selected as a founding member of the National Dairy Technology Innovation Center Council, reinforcing our role in China's HMO industry.
Global Expansion Begins
Presented HMO product lines at the 2022 World Advanced Manufacturing Conference. Began serving international nutrition and wellness brands.
Global Expansion Begins
Presented HMO product lines at the 2022 World Advanced Manufacturing Conference. Began serving international nutrition and wellness brands.
LNTr II Milestone — First FDA GRAS Globally
Achieved the world's first FDA GRAS notification for LNTr II (Lacto-N-Triose II), setting a new safety and regulatory benchmark for next-generation HMOs.
LNTr II Milestone — First FDA GRAS Globally
Achieved the world's first FDA GRAS notification for LNTr II (Lacto-N-Triose II), setting a new safety and regulatory benchmark for next-generation HMOs.
Full Product Portfolio Launched
Expanded to 7 HMO variants, sea cucumber peptide, and salidroside product lines. Achieved FSSC 22000, ISO 9001, Halal, GMP, and EU Novel Food certifications.
Full Product Portfolio Launched
Expanded to 7 HMO variants, sea cucumber peptide, and salidroside product lines. Achieved FSSC 22000, ISO 9001, Halal, GMP, and EU Novel Food certifications.
50+ Countries Served
Products distributed to nutrition, wellness, and skincare brands across 50+ countries. Maintained 110+ global patents in biosynthesis.
50+ Countries Served
Products distributed to nutrition, wellness, and skincare brands across 50+ countries. Maintained 110+ global patents in biosynthesis.
Morika Bio Global Launch
Launched the Morika Bio brand for international markets, built on the 3rd-Gen Precision Yeast Synthesis platform — delivering endotoxin-free, pharmaceutical-grade bio-active ingredients worldwide.
Morika Bio Global Launch
Launched the Morika Bio brand for international markets, built on the 3rd-Gen Precision Yeast Synthesis platform — delivering endotoxin-free, pharmaceutical-grade bio-active ingredients worldwide.